Compugen Ltd. - Ordinary Shares (CGEN) Social Stream



Compugen Ltd. - Ordinary Shares (CGEN): $0.70

-0.02 (-2.47%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CGEN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 379

in industry

COMPUGEN LTD (CGEN) Price Targets From Analysts

Use the tables below to see what analysts covering COMPUGEN LTD think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-11 5 $28 $16 $21.333 $0.725 2842.48%
2021-11-15 6 $28 $16 $21.333 $0.725 2842.48%
2021-12-10 6 $28 $16 $21 $0.725 2796.55%
2022-02-04 6 $25 $14 $18.666 $0.725 2474.62%
2022-02-25 6 $25 $14 $16.666 $0.725 2198.76%
2022-04-27 6 $25 $9 $15 $0.725 1968.97%
2022-05-17 6 $14 $9 $12.166 $0.725 1578.07%
2022-08-04 6 $14 $9 $11.833 $0.725 1532.14%
2022-08-08 7 $14 $2 $8.571 $0.725 1082.21%
2022-08-23 7 $14 $2 $7.142 $0.725 885.1%
2022-10-14 7 $14 $2 $7 $0.725 865.52%
2022-11-15 7 $14 $2 $6.428 $0.725 786.62%
2023-01-05 7 $13 $1 $6.142 $0.725 747.17%
2023-02-08 6 $13 $0.5 $6.071 $0.725 737.38%
2023-02-28 7 $13 $0.5 $6.071 $0.725 737.38%
2023-03-06 7 $13 $0.5 $5.642 $0.725 678.21%

The Trend in the Analyst Price Target


CGEN's average price target has moved down $15.36 over the prior 15 months.

Over the past 45 weeks, CGEN's average upside potential has been 595.88%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-08 7 14 2.0 8.571 1.480 479.12%
2022-08-08 6 14 2.0 8.571 1.480 479.12%
2022-11-15 7 14 1.0 6.285 0.867 624.91%
2023-01-05 8 13 1.0 6.142 0.880 597.95%
2023-02-08 7 13 0.5 6.071 0.843 620.17%

CGEN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.43 6 0 0 0 0 7

The Trend in the Broker Recommendations


CGEN's average broker recommendation rating worsened by 0.43 over the prior 36 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CGEN as an investment opportunity.

  • In terms of how COMPUGEN LTD fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1934.85% of that group.
  • To contextualize these metrics, consider that out of all US stocks, COMPUGEN LTD's average analyst price target is higher than 257.46% of them.
  • In terms of how COMPUGEN LTD fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -1569.79% of that group.
  • CGEN has a greater number of analysts covering the stock than 1561.26% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to COMPUGEN LTD are ONVO, XTNT, and ADMA.

What is the outlook for CGEN? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7228 seconds.